Valuation: Novartis AG

Market Cap 277B 244B 231B 209B 393B 26,633B 395B 2,763B 1,067B 13,590B 1,042B 1,019B 43,671B P/E 2026 *
20.7x
P/E 2027 * 17.3x
Enterprise Value 309B 272B 257B 233B 438B 29,650B 440B 3,076B 1,188B 15,130B 1,160B 1,135B 48,619B EV / Sales 2026 *
5.36x
EV / Sales 2027 * 4.98x
Free-Float
91.66%
Yield 2026 *
2.98%
Yield 2027 * 3.11%
1 day-0.44%
1 week+3.66%
Current month-2.06%
1 month-2.06%
3 months-4.34%
6 months+0.75%
Current year+10.15%
1 week 116.16
Extreme 116.16
122.36
1 month 110.3
Extreme 110.3
132.68
Current year 107.68
Extreme 107.68
132.68
1 year 97.05
Extreme 97.05
132.68
3 years 81.1
Extreme 81.1
132.68
5 years 72.84
Extreme 72.84
132.68
10 years 65.09
Extreme 65.09
132.68
Manager TitleAgeSince
Chief Executive Officer 50 31/01/2018
Director of Finance/CFO - 15/03/2026
Compliance Officer 58 13/04/2025
Director TitleAgeSince
Director/Board Member 67 31/12/2014
Director/Board Member 69 31/12/2015
Director/Board Member 61 31/12/2015
Date Insider Type Main position Quantity % Market Cap. Importance
18/05/26 Sell -5,200 0.0003%
04/05/26 Sell 6,800 0.0003%
17/02/26 Sell 30,743 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-0.49%+3.66%+21.88%+28.60% 277B
-0.90%-0.06%+60.97%+117.73% 1,056B
-1.92%-1.30%+46.29%+70.59% 655B
-1.46%-1.14%+17.49%+75.89% 471B
-1.80%-4.15%+36.27%+39.35% 342B
-0.40%-1.86%+12.16%+12.02% 257B
-0.50%+1.36%+51.78%+54.72% 226B
-1.91%-2.23%+32.53%+99.17% 189B
-0.24%-2.82%-28.45%-60.94% 170B
-1.27%+1.32%+18.66%-14.68% 164B
Average -1.10%+1.24%+26.96%+42.25% 380.66B
Weighted average by Cap. -1.20%+1.16%+36.94%+65.45%

Financials

2026 *2027 *
Net sales 57.65B 50.7B 47.95B 43.49B 81.67B 5,534B 82.15B 574B 222B 2,824B 216B 212B 9,074B 61.41B 54.01B 51.07B 46.32B 87B 5,895B 87.5B 612B 236B 3,008B 231B 226B 9,666B
Net income 14.21B 12.5B 11.82B 10.72B 20.13B 1,364B 20.25B 141B 54.65B 696B 53.35B 52.19B 2,237B 15.78B 13.88B 13.13B 11.91B 22.36B 1,515B 22.49B 157B 60.7B 773B 59.25B 57.97B 2,484B
Net Debt 31.43B 27.64B 26.14B 23.71B 44.53B 3,017B 44.79B 313B 121B 1,540B 118B 115B 4,947B 28.26B 24.85B 23.5B 21.32B 40.03B 2,713B 40.27B 281B 109B 1,384B 106B 104B 4,448B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
29/09/26 CHF 120.96 -0.36% 1,565,552
28/09/26 CHF 121.40 +1.34% 3,002,035
25/09/26 CHF 119.80 +0.71% 3,352,962
24/09/26 CHF 118.96 +1.16% 3,316,969
23/09/26 CHF 117.60 +0.98% 3,261,410
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
23
Last Close Price
145.97USD
Average target price
152.43USD
Spread / Average Target
+4.42%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock